Fresenius Warned By FDA To Clean Up Its Act
Fresenius medical healthcare group announced yesterday that it has been warned by the FDA that it needs improve procedures at a blood bag manufacturing plant in Puerto Rico, according to Reuters. In question were the company’s labeling and complaint-handling procedures. The company made certain to assure interested parties that it did not foresee the issues with the Puerto Rico plant affecting sales or earnings and added that patients had not been put at risk. This is far from Fresenius’s first brush with the law and the largest issue looming for the Germany-based healthcare giant revolves around safety issues associated...
Read More